Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis

Fig. 1

a Chemical structure of KRO-105714. b The inhibitory effects of KRO-105714 on the proliferation of SPC-induced NIH3T3 cells. The cells were exposed to various concentrations of KRO-105714 for 30 min, and then treated with 10 μM of SPC for 24 h. Then inhibition rates were calculated by comparing the corresponding viability values of the control group. Each sample was assayed in triplicate

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us